NCT03257462View on ClinicalTrials.gov

Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 12, 2017

Primary Completion Date

March 2, 2019

Study Completion Date

March 29, 2019

Conditions
Congenital Adrenal HyperplasiaCAH - Congenital Adrenal Hyperplasia
Interventions
DRUG

SPR001

SPR001 Capsules

Trial Locations (9)

19104

Spruce Biosciences Clinical Site, Philadelphia

30046

Spruce Biosciences Clinical Site, Atlanta

32935

Spruce Biosciences Clinical Site, Melbourne

46202

Spruce Biosciences Clinical Site, Indianapolis

48109

Spruce Biosciences Clinical Site, Ann Arbor

55414

Spruce Biosciences Clinical Site, Minneapolis

89148

Spruce Biosciences Clinical Site, Las Vegas

92123

Spruce Biosciences Clinical Site, Orange

Spruce Biosciences Clinical Site, San Diego

Sponsors

Lead Sponsor

Spruce Biosciences
All Listed Sponsors
lead

Spruce Biosciences

INDUSTRY

NCT03257462 - Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia | Biotech Hunter | Biotech Hunter